Lorient Capital Management, LLC (the “Firm”) is a Delaware limited liability company. The Firm’s principal place of business is located in Miami, Florida. The Firm also has an additional place of business located in Birmingham, Michigan. As indicated on the Firm’s Form ADV Part 1A, the Firm’s principal shareholders are DaBermz, LLC and Broome Capital Partners, LLC (the “Principals”), which are solely owned by David Berman and Jordan Broome, respectively. Lorient Capital Management, LLC provides discretionary investment advisory services to privately offered pooled investment vehicles: Lorient Healthcare Fund, LP (the “Healthcare Fund”), Lorient Healthcare Parallel Fund, LP (the “Healthcare Parallel Fund”, and together with the Healthcare Fund referred to as “Fund I”), Lorient Healthcare Fund II, LP (the “Healthcare Fund II”), Lorient Healthcare Parallel Fund II, LP (the “Healthcare Parallel Fund II, and together with the Healthcare Fund II referred to as “Fund II”), Lorient Healthcare GP II Investment, LP (“Healthcare GP II Investment”), Lorient Healthcare Fund III, LP (the “Healthcare Fund III” or “Fund III”), Lorient Healthcare GP III Investment, LP (“Healthcare GP III Investment”), Lorient Eagle Investment, LP (“Eagle Investment”), Lorient Eagle Investment GP, LP (“Eagle Investment Feeder”), Lorient Peregrine Investment, LP (“Peregrine”), Lorient Peregrine GP Investment, LP (“Peregrine GP Investment”), and Lorient Shiftkey Investment, LP (“Shiftkey”), which are Delaware limited partnerships (together, the “Funds”); and, Lorient KCMP, LLC (“KCMP”), which are Delaware limited liability companies, and Transitions Acquisition, LP (the “Transitions Fund”), Lorient VBF Co-Invest, LP (“VBF”), and LC II ABD Co-Invest, LP (“ABD”), which are Delaware Limited Partnerships (together, the “Co-investment Vehicles,” and collectively with the Funds, “Advisory Clients”). Lorient Healthcare GP, LLC is the general partner (“Fund I GP”) of the Healthcare Fund, the Healthcare Parallel

Fund, KCMP and Centria. Lorient Healthcare GP II, LLC is the general partner (“Fund II GP”) of Healthcare Fund II, Healthcare Parallel Fund II, and the Healthcare GP II Investment. Lorient Healthcare GP III, LLC is the general partner (“Fund III GP”) of Healthcare Fund III. Lorient Eagle GP, LLC is the general partner (“Eagle GP”) of Eagle Investment and Eagle Investment Feeder. Lorient Shiftkey GP, LLC is the general partner (“Shiftkey GP”) of Shiftkey. Lorient VBF GP, LLC is the general partner (“VBF GP”) of VBF. Lorient Transitions, LLC is the general partner (“Transitions GP”) of the Transitions Fund. Lorient Peregrine GP, LLC is the general partner (“Peregrine GP”) of Peregrine and Peregrine GP Investment. Lorient ABD Co-Invest GP, LLC is the general partner (“ABD GP”) of ABD. Together, all general partners are referred to as the “General Partners.” The Adviser will manage the investments of the Advisory Clients in accordance with each fund’s governing and offering documents (“Fund Documents”). Lorient’s Advisory Clients will primarily seek control investments in the form of equity securities of “micro” middle-market growth companies operating in the healthcare services industry, with a particular focus in the areas of physician practice management, post-acute care, behavioral health, and business process outsourcing. Subscriptions in the Advisory Clients are advised by Lorient and are limited to sophisticated investors. Lorient’s advisory services provided to its Advisory Clients are pursuant to the relevant offering documents and based on the specific investment objectives and strategies as disclosed therein. Investors cannot obtain services tailored to their individual specific needs. Not applicable. Lorient does not participate in a wrap fee program. As of December 31, 2023, Lorient managed approximately $1,361,013,763 in regulatory assets under management on a discretionary basis. Lorient does not intend to manage any assets on a non-discretionary basis.